British Journal of Cancer

Published by: Nature Publishing Group  

People

  1. Pike
    Pike
  2. Vickers
    Vickers
  3. Lilja
    Lilja
  4. Bernstein
    Bernstein
  5. Begg
    Begg
  6. Gonen
    Gonen
  7. Liang
    Liang
  8. Scardino
    Scardino
  9. Capanu
    Capanu
  10. Carlsson
    Carlsson

Groups

  1. Epidemiology and Biostatistics (34)
  2. Population Sciences Research Program (24)
  3. Epidemiology Service (16)
  4. Biostatistics Service (15)
  5. Surgery (12)
  6. Survivorship Research (12)
  7. Health Outcomes Research Group (11)
  8. Department of Medicine (10)
  9. Solid Tumor Oncology Division (10)
  10. Urology (8)
Search Within
  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (32)
  2. Meeting Abstract (1)
  3. Review (1)
Groups
  1. Epidemiology and Biostatistics (34)
  2. Population Sciences Research Program (24)
  3. Epidemiology Service (16)
  4. Biostatistics Service (15)
  5. Surgery (12)
  6. Survivorship Research (12)

More Groups

People
  1. Malcolm Pike (7)
  2. Andrew Vickers (6)
  3. Hans Lilja (5)
  4. Sara Olson (5)
  5. Jonine Bernstein (4)
  6. Colin Begg (3)

More People

Years
  1. 2024 (1)
  2. 2022 (3)
  3. 2021 (3)
  4. 2020 (1)
  5. 2019 (2)
  6. 2018 (3)

More Years

Publishers
  1. Nature Publishing Group (34)

Results (34)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pre-diagnosis tea and coffee consumption and survival after a diagnosis of ovarian cancer: Results from the Ovarian Cancer Association Consortium
    Journal Article

    Nagle, C. M.; Ibiebele, T. I.; Bandera, E. V.; Cramer, D.; Doherty, J. A.; Giles, G. G.; Goodman, M. T.; Hanley, G. E.; Harris, H. R.; Jensen, A.; more...
    British Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Associations between circulating proteins and risk of breast cancer by intrinsic subtypes: A Mendelian randomisation analysis
    Journal Article

    Shu, X.; Zhou, Q.; Sun, X.; Flesaker, M.; Guo, X.; Long, J.; Robson, M. E.; Shu, X. O.; Zheng, W.; Bernstein, J. L.
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Independent validation of a pre-specified four-kallikrein marker model for prediction of adverse pathology and biochemical recurrence
    Journal Article

    Rasmussen, M.; Fredsøe, J.; Tin, A. L.; Vickers, A. J.; Ulhøi, B.; Borre, M.; Eastham, J.; Ehdaie, B.; Guillonneau, B.; Laudone, V.; more...
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Immune biomarkers and response to checkpoint inhibition of BRAF(V600) and BRAF non-V600 altered lung cancers
    Journal Article

    Murciano-Goroff, Y. R.; Pak, T.; Mondaca, S.; Flynn, J. R.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Plodkowski, A. J.; Wu, S. L.; Kris, M. G.; more...
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Randomised phase 1 clinical trials in oncology
    Review

    Iasonos, A.; O’Quigley, J.
    British Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma
    Journal Article

    Teo, M. Y.; Al-Ahmadie, H.; Seier, K.; Tully, C.; Regazzi, A. M.; Pietzak, E.; Solit, D. B.; Tickoo, S.; Reuter, V.; Cha, E. K.; more...
    British Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Searching for causal relationships of glioma: A phenome-wide Mendelian randomisation study
    Journal Article

    Saunders, C. N.; Cornish, A. J.; Kinnersley, B.; Law, P. J.; Houlston, R. S.; and Collaborators
    British Journal of Cancer (2021)

    Fulltext@MSK | Save
  • A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy
    Journal Article

    Haese, A.; Tin, A. L.; Carlsson, S. V.; Sjoberg, D. D.; Pehrke, D.; Steuber, T.; Huland, H.; Graefen, M.; Scardino, P. T.; Schlomm, T.; more...
    British Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Interim results from the IMPACT study: Evidence for PSA screening in BRCA2 mutation carriers
    Meeting Abstract

    Page, E.; Bancroft, E.; Brook, M.; Assel, M.; Offman, J.; Kote-Jarai, Z.; Vickers, A.; Lilja, H.; Eeles, R.
    British Journal of Cancer (2019)

    Fulltext@MSK | Save
  • Long-term survival in patients with metastatic head and neck squamous cell carcinoma treated with metastasis-directed therapy
    Journal Article

    Beckham, T. H.; Leeman, J. E.; Xie, P.; Li, X.; Goldman, D. A.; Zhang, Z.; Sherman, E.; McBride, S.; Riaz, N.; Lee, N.; more...
    British Journal of Cancer (2019)

    Fulltext@MSK | Save

    • British Journal of Cancer – authorized name for:

    Name ISSN / ISBN Publisher
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 00070920 Macmillan Publishers Limited
    British Journal of Cancer 0007-0920 Macmillan Publishers Limited
    British Journal of Cancer 00070920 The Author(s) 2024
    British Journal of Cancer 0007-0920 Unknown
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 15321827 Unknown
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 00070920 2023, The Author(s), Under Exclusive Licence To Springer Nature Limited
    British Journal of Cancer 15321827 Cancer Research Uk
    British Journal of Cancer 00070920 2022, The Author(s), Under Exclusive Licence To Springer Nature Limited
    British Journal of Cancer 0007-0920 Churchill Livingstone
    British Journal of Cancer 15321827 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 00070920 Cancer Research Uk
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 00070920 Cancer Research
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 00070920 The Author(s)
    British Journal of Cancer 00070920 2019, Cancer Research Uk
    British Journal of Cancer 00070920 2018, Cancer Research Uk
    British Journal of Cancer 00070920 2022, The Author(s)
    British Journal of Cancer 00070920 2023, The Author(s)
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Cancer Research Uk
    British Journal of Cancer 00070920 Cancer Research Campaign
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 00070920 The Author(s), Under Exclusive Licence To Springer Nature Limited 2024
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 00070920 2021, The Author(s), Under Exclusive Licence To Springer Nature Limited
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 00070920 Unknown
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 00070920 2018, The Author(s)
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Stockton Press
    British Journal of Cancer 0007-0920 Nature Publishing Group
    Unknown (0007-0920) 0007-0920 Unknown